Dexamethasone Tablet Franchise in Ahmedabad

Anti-Inflammatory Tablet Supplier in Mumbai

Immunosuppressant Medicine Distributor in Delhi

Corticosteroid Pharma Franchise in Bangalore

Dexamethasone Tablet Stockist in Hyderabad
Anti-Inflammatory & Allergy Tablet Manufacturer & Exporter in Chandigarh

Home/Products /dexamethasone-8mg-tablet

Dexaflip 8 Tablet

Composition : Dexamethasone (8mg) Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹0/-

Please Contact For Best Price

Dexaflip 8 Tablet contains Dexamethasone 8mg, a high-strength corticosteroid for managing severe inflammation, autoimmune disorders, and acute allergic reactions. Its powerful anti-inflammatory action helps reduce swelling, suppress immune overactivity, and alleviate pain effectively.

This tablet is widely prescribed for moderate to severe arthritis, asthma exacerbations, dermatological conditions, and autoimmune diseases, ensuring rapid and effective symptom control for patients requiring high-potency therapy.

For franchise partners, Dexaflip 8 Tablet is a high-demand product in the anti-inflammatory and immunosuppressant segment, offering strong repeat prescriptions and market stability. Its clinical significance ensures profitable growth and enhanced portfolio value.

With increasing need for advanced corticosteroid therapies, Dexaflip 8 Tablet provides sustainable business opportunities, allowing partners to expand their presence in the anti-inflammatory and immunosuppressive care segment.

Read More

About the Product

Dexaflip 8 Tablet contains Dexamethasone 8mg, a high-strength corticosteroid for managing severe inflammation, autoimmune disorders, and acute allergic reactions. Its powerful anti-inflammatory action helps reduce swelling, suppress immune overactivity, and alleviate pain effectively.

This tablet is widely prescribed for moderate to severe arthritis, asthma exacerbations, dermatological conditions, and autoimmune diseases, ensuring rapid and effective symptom control for patients requiring high-potency therapy.

For franchise partners, Dexaflip 8 Tablet is a high-demand product in the anti-inflammatory and immunosuppressant segment, offering strong repeat prescriptions and market stability. Its clinical significance ensures profitable growth and enhanced portfolio value.

With increasing need for advanced corticosteroid therapies, Dexaflip 8 Tablet provides sustainable business opportunities, allowing partners to expand their presence in the anti-inflammatory and immunosuppressive care segment.

Common side effects may include increased appetite, weight gain, mood swings, insomnia, and gastrointestinal discomfort. Prolonged use can lead to elevated blood sugar, osteoporosis, muscle weakness, or heightened risk of infections. Any persistent or serious adverse effects should be reported to a healthcare professional immediately.

Dexaflip 8 Tablet is indicated for the treatment of inflammatory and allergic conditions such as severe asthma, rheumatoid arthritis, skin disorders, autoimmune diseases, and acute allergic reactions. It may also be used in certain endocrine disorders and as part of specific cancer therapies, under physician supervision.

Dexaflip 8 Tablet should be taken exactly as prescribed. Do not discontinue the medicine abruptly, as it may cause withdrawal symptoms. Caution is advised for patients with diabetes, high blood pressure, infections, or liver/kidney disorders. Regular monitoring by a physician is recommended for long-term therapy.

Store Dexaflip 8 Tablet in a cool, dry place below 25°C, protected from light and moisture. Keep out of reach of children and avoid using beyond the expiry date indicated on the pack.

Get in Touch